Two Years of Denosumab and Teriparatide Administration in Postmenopausal Women With Osteoporosis (The DATA Extension Study): A Randomized Controlled Trial

CONTEXT: Current osteoporosis medications increase bone mineral density (BMD) modestly and reduce, but do not eliminate, fracture risk. Attempts to improve efficacy by administering anabolic agents and bisphosphonates concomitantly have been unsuccessful. Conversely, 12 months of concomitant denosum...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Leder, Benjamin Z., Tsai, Joy N., Uihlein, Alexander V., Burnett-Bowie, Sherri-Ann M., Zhu, Yuli, Foley, Katelyn, Lee, Hang, Neer, Robert M.
Formato: Artigo
Idioma:Inglês
Publicado em: Endocrine Society 2014
Assuntos:
Endocrine Care
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4010689/
https://ncbi.nlm.nih.gov/pubmed/24517156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2013-4440
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados